Page last updated: 2024-09-04

rupatadine and Embolism, Pulmonary

rupatadine has been researched along with Embolism, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Antonopoulou, S; Demopoulos, C; Theoharides, TC	1

Reviews

1 review(s) available for rupatadine and Embolism, Pulmonary

Article	Year
COVID-19, microthromboses, inflammation, and platelet activating factor. BioFactors (Oxford, England), 2020, Volume: 46, Issue:6 Topics: Antiviral Agents; Blood Platelets; COVID-19; Cyproheptadine; Disseminated Intravascular Coagulation; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lung; Luteolin; Mast Cells; Platelet Activating Factor; Pulmonary Embolism; Quercetin; SARS-CoV-2; Severe Acute Respiratory Syndrome	2020

Article

Year

COVID-19, microthromboses, inflammation, and platelet activating factor.

BioFactors (Oxford, England), 2020, Volume: 46, Issue:6

Topics: Antiviral Agents; Blood Platelets; COVID-19; Cyproheptadine; Disseminated Intravascular Coagulation; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lung; Luteolin; Mast Cells; Platelet Activating Factor; Pulmonary Embolism; Quercetin; SARS-CoV-2; Severe Acute Respiratory Syndrome

2020